#BTFBenefit2014 |
- a clinical trial for the treatment of neuroblastoma has been submitted to the FDA for approval and
- 10 PATIENTS who have been treated with T-cell therapy ARE IN REMISSION!
Ten patients who had experienced relapse, who had no other treatment options - whose hope for a cure was completely exhausted, and were facing death - those ten children are now in remission.
Ten families are not heartbroken today - parents, siblings, extended family and community - have their precious, beloved child with them. Ten families did not have to sign "do not resuscitate" forms, did not have to request hospice care, did not have to plan a memorial service, pick a headstone, face an empty bedroom.
Ten.
Your donations to the Katie Gerstenberger Endowment support this ground-breaking, life-restoring work. Thank you!